Quintiles has signed a deal with Population Genetics Technologies (PGT) that, it says, will bring large-scale genomics analysis into the drug development mainstream.
India’s Veeda Clinical Research has set up a Phase I unit in Malaysia, joining the growing list of contract research organisations (CRO) attracted to the country.
Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including appointments at Icon, Quintiles, Catalent and CRF Health.
Indian CRO GVK Biosciences has been named as a preferred provider by a consortium, Product Development Partners (PDP), which is focused on drugs for neglected diseases.
Primary packaging maker Schott has joined the growing list of drug industry companies seeking to tap Russian government demand for increased domestic manufacturing.
Phlexglobal, a contract research organisation (CRO) specialising in trial master file (TMF) and eTMF management, has expanded its US operations with the opening of an office in Philadelphia, Pennsylvania.
EMD Millipore has opened a training facility in China as an education resource for the country’s rapidly expanding biopharmaceutical manufacturing and development sector.
Pharmaceutical intermediate sales helped Codexis in Q1 but the US biocatalysis specialist still posted a net loss for the quarter on higher R&D spending
Quality issues slowed first quarter revenue growth at Teva but, with one plant resuming shipping and another awaiting re-inspection, sales are expected to pick up.
Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including appointments at Penn Pharma, Almac and Beardsworth.
A new direct flight between London Heathrow and San Diego from 1st June 2011 will benefit the international biotech sector according to UK-based Biotec Services International.
Pharma industry wishful thinking and the fact too many developers have been chasing too few targets are behind an increase in Phase II failures in recent years according to a new study.
Chemicals supplier Aceto Corp has its sights set on opportunities in the generic drug sector after soaring active pharmaceutical ingredient (API) and intermediates sales helped it to a strong set of quarterly financials.
Northern Ireland-based Almac Group has launched its selectAZyme brand, which provides a wide range of enzymes such as reductases, hydrolases, nitrolases for manufacturing applications.
Carbogen Amcis’s Indian plant has met industrial standards for the containment and handling of highly potent active pharmaceutical ingredients (HPAPI).
SCM will work with Italy’s Molteni Therapeutics on production of trial supplies an innovative candidate treatment for diabetic ulcers under a deal announced last week.
Merck South Africa, a subsidiary of German pharma giant, Merck KGaA, has sold its Merck Pharmaceutical Manufacturing (MPM) operations in Johannesburg to investment firm, Nkunzi Investment Holdings.
Albany Molecular Research (AMRI) posted a modest net loss on costs and restructuring charges, but saw revenue grow considerably in the first quarter thanks to contracting business and royalties.
Last week non-clinical CRO CIT bought Canadian counterpart LAB Research. Outsourcing-pharma.com spoke with CIT executive chairman Jean-Francois Le Bigot about the deal and the plan going forward.
Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including appointments at CMC Biologics, PharmaNet and AAIPharma.
Prosonix and Italian partner Sterling have completed the commercialisation of a respiratory active pharmaceutical ingredient (API) using the UK firm’s unique particle engineering technology.
Non-profit epilepsy research sponsor, Epilepsy Therapy Project (ETP), has announced it is to invest in central nervous system (CNS) drug delivery specialist, ICVrx, to support the development of novel drug tech designed to tackle refractory epilepsy.
